Lv5
856 积分 2023-03-12 加入
Noninvasive Imaging of Claudin 18.2 Expression in Gastric Adenocarcinoma: Synthesis, Preclinical Evaluation, and Preliminary Clinical Study of a Novel [89Zr]Zr-DFO-NY005 Immuno-Positron Emission Tomography Tracer
2个月前
已完结
Computer-aided diagnostics helps to accurately determine different expression levels of claudin-18.2 in gastric cancer
2个月前
已完结
[Expert consensus on Claudin18.2 expression testing in gastric cancer (2025 version)]
2个月前
已完结
Biomarker: Predictive or Prognostic?
2个月前
已完结
Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
2个月前
已完结
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology
2个月前
已完结
HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study
2个月前
已完结
Trogocytosis-orchestrated CLDN18.2-“dressed” CD8 + T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade
2个月前
已完结
Interferon-γ: an overview of signals, mechanisms and functions
2个月前
已完结
CELLULAR RESPONSES TO INTERFERON-γ
2个月前
已完结
皖公网安备34019202002308
